business

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

Investing.com · Jun 8, 2026, 12:30 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Johnson & Johnson acquires Firefly Bio for $1 billion STAT News STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments Yahoo Finance Spacecraft developer Quantum Space to go public in $1.2 billion SPAC deal

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

Also covered by

More in business